Skip to main content

Table 4 Multivariate predictors of CD4 change at 12 months in HIV-infected individuals at Jimma University Specialized Hospital, January 2006 to December 2011

From: Nutritional status and its effect on treatment outcome among HIV infected clients receiving HAART in Ethiopia: a cohort study

Variables

Numbers

B [95 % CI]

p value

Age

340

−1.91 [−3.238, −0.582]

0.005

Sex

 Female

200

Reference

 

 Male

140

−38.67 [−81.973, 4.633]

0.080

BMI

 <18.5

170

−21.54 [−64.197, 21.109]

0.321

 ≥18.5

170

Reference

 

HAART regimen

 Stavudine based

219

25.57 [−34.277, 85.420]

0.401

 Zidovudine based

72

−17.53 [−87.25, 52.190]

0.621

 Tenofovir based

49

Reference

 

Baseline CD4

 <100

5

188.75 [−9.859, 387.359]

0.062

 100–199

94

201.29 [2.916, 399.661]

0.047

 200–350

139

133.33 [−64.785, 81.773]

0.186

 >350

102

Reference

 

WHO stage

 Stage 1

65

Reference

 

 Stage 2

95

−15.96 [−78.139, 46.212]

0.614

 Stage 3

144

24.17 [−33.426, 81.773]

0.179

 Stage 4

36

−63.89 [−157.331, 29.548]

0.409

Educational status

 Not educated

69

Reference

 

 Primary

122

52.75 [−4.906, 110.408]

0.073

 Secondary

106

40.11 [−18.174, 98.400]

0.177

 Tertiary

42

40.113 [−76.277, 83.098]

0.933